IP Verse

Modified Messenger Rna Comprising Functional Rna Elements - EP3625345

The patent EP3625345 was granted to Moderna on May 24, 2023. The application was originally filed on May 18, 2018 under application number EP18731259A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3625345

MODERNA
Application Number
EP18731259A
Filing Date
May 18, 2018
Status
Granted And Under Opposition
Apr 21, 2023
Grant Date
May 24, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

PFIZERFeb 26, 2024EDERADMISSIBLE
BIONTECHFeb 23, 2024THOMANNADMISSIBLE

Patent Citations (192) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2012US58519-
DESCRIPTIONWO2012US69610-
DESCRIPTIONWO2013US30062-
DESCRIPTIONWO2014US27077-
DESCRIPTIONWO2014US55394-
DESCRIPTIONWO2015US27400-
DESCRIPTIONWO2016US00129-
DESCRIPTIONWO2016US14280-
DESCRIPTIONWO2016US47406-
DESCRIPTIONWO2016US52117-
DESCRIPTIONWO2016US52352-
DESCRIPTIONWO2016US59575-
DESCRIPTIONWO2016US68300-
DESCRIPTIONWO2016US69491-
DESCRIPTIONWO2017US27492-
DESCRIPTIONWO2017US37551-
DESCRIPTIONWO2017US38426-
DESCRIPTIONUS2003073619
DESCRIPTIONUS2004142474
DESCRIPTIONUS2004262223
DESCRIPTIONUS2005059005
DESCRIPTIONUS2005222064
DESCRIPTIONUS2005261218
DESCRIPTIONUS2009226470
DESCRIPTIONUS2010004315
DESCRIPTIONUS2010068285
DESCRIPTIONUS2010068286
DESCRIPTIONUS2010069426
DESCRIPTIONUS2010087337
DESCRIPTIONUS2010104645
DESCRIPTIONUS2010104655
DESCRIPTIONUS2010129877
DESCRIPTIONUS2010216804
DESCRIPTIONUS2010293625
DESCRIPTIONUS2011217377
DESCRIPTIONUS2011262491
DESCRIPTIONUS2011274759
DESCRIPTIONUS2012004293
DESCRIPTIONUS2012009145
DESCRIPTIONUS2012140790
DESCRIPTIONUS2012178702
DESCRIPTIONUS2012201859
DESCRIPTIONUS2012276209
DESCRIPTIONUS2012288541
DESCRIPTIONUS2013059360
DESCRIPTIONUS2013072709
DESCRIPTIONUS2013123351
DESCRIPTIONUS2013129726
DESCRIPTIONUS2013137644
DESCRIPTIONUS2013142818
DESCRIPTIONUS2013150295
DESCRIPTIONUS2013164219
DESCRIPTIONUS2013171241
DESCRIPTIONUS2013171646
DESCRIPTIONUS2013172406
DESCRIPTIONUS2013177633
DESCRIPTIONUS2013177634
DESCRIPTIONUS2013177635
DESCRIPTIONUS2013177636
DESCRIPTIONUS2013177637
DESCRIPTIONUS2013177638
DESCRIPTIONUS2013183244
DESCRIPTIONUS2013183372
DESCRIPTIONUS2013183373
DESCRIPTIONUS2013183375
DESCRIPTIONUS2013184453
DESCRIPTIONUS2013189351
DESCRIPTIONUS2013195799
DESCRIPTIONUS2013195920
DESCRIPTIONUS2013195968
DESCRIPTIONUS2013195969
DESCRIPTIONUS2013196948
DESCRIPTIONUS2013202684
DESCRIPTIONUS2013211249
DESCRIPTIONUS2013217753
DESCRIPTIONUS2013230567
DESCRIPTIONUS2013231287
DESCRIPTIONUS2013261012
DESCRIPTIONUS2014200261
DESCRIPTIONUS2016022840
DESCRIPTIONUS5505931
DESCRIPTIONUS5563250
DESCRIPTIONUS5723332
DESCRIPTIONUS5807707
DESCRIPTIONUS5891665
DESCRIPTIONUS6004573
DESCRIPTIONUS6177274
DESCRIPTIONUS6217912
DESCRIPTIONUS6265389
DESCRIPTIONUS6267987
DESCRIPTIONUS6426086
DESCRIPTIONUS6517869
DESCRIPTIONUS6555525
DESCRIPTIONUS6586524
DESCRIPTIONUS6652886
DESCRIPTIONUS6696038
DESCRIPTIONUS6835393
DESCRIPTIONUS6897196
DESCRIPTIONUS7098032
DESCRIPTIONUS7138382
DESCRIPTIONUS7374778
DESCRIPTIONUS7404969
DESCRIPTIONUS7737108
DESCRIPTIONUS8003129
DESCRIPTIONUS8057821
DESCRIPTIONUS8158601
DESCRIPTIONUS8206747
DESCRIPTIONUS8236280
DESCRIPTIONUS8236330
DESCRIPTIONUS8241670
DESCRIPTIONUS8246968
DESCRIPTIONUS8293276
DESCRIPTIONUS8313777
DESCRIPTIONUS8318208
DESCRIPTIONUS8318211
DESCRIPTIONUS8444992
DESCRIPTIONUS8450298
DESCRIPTIONUS8460696
DESCRIPTIONUS8501824
DESCRIPTIONUS8507653
DESCRIPTIONUS8519110
DESCRIPTIONUS8524259
DESCRIPTIONUS8524368
DESCRIPTIONWO2006063249
DESCRIPTIONWO2008103276
DESCRIPTIONWO2008121949
DESCRIPTIONWO2010005721
DESCRIPTIONWO2010005723
DESCRIPTIONWO2010005725
DESCRIPTIONWO2010005726
DESCRIPTIONWO2010005740
DESCRIPTIONWO2010030763
DESCRIPTIONWO2010075072
DESCRIPTIONWO2010087791
DESCRIPTIONWO2011062965
DESCRIPTIONWO2011084518
DESCRIPTIONWO2011084521
DESCRIPTIONWO2011127255
DESCRIPTIONWO2012006376
DESCRIPTIONWO2012006378
DESCRIPTIONWO2012006380
DESCRIPTIONWO2012013326
DESCRIPTIONWO2012025129
DESCRIPTIONWO2012030901
DESCRIPTIONWO2012031043
DESCRIPTIONWO2012031046
DESCRIPTIONWO2012040524
DESCRIPTIONWO2012045075
DESCRIPTIONWO2012054923
DESCRIPTIONWO2012099755
DESCRIPTIONWO2012109121
DESCRIPTIONWO2012110636
DESCRIPTIONWO2012170889
DESCRIPTIONWO2012170930
DESCRIPTIONWO2013033438
DESCRIPTIONWO2013078199
DESCRIPTIONWO2013082111
DESCRIPTIONWO2013086322
DESCRIPTIONWO2013086354
DESCRIPTIONWO2013086526
DESCRIPTIONWO2013103659
DESCRIPTIONWO2013105101
DESCRIPTIONWO2013106072
DESCRIPTIONWO2013106073
DESCRIPTIONWO2013106086
DESCRIPTIONWO2013110028
DESCRIPTIONWO2013116126
DESCRIPTIONWO2013123298
DESCRIPTIONWO2013123523
DESCRIPTIONWO2013124867
DESCRIPTIONWO2014081507
DESCRIPTIONWO2014093924
DESCRIPTIONWO2014159813
DESCRIPTIONWO2014164253
DESCRIPTIONWO2015051214
DESCRIPTIONWO2015130584
INTERNATIONAL-SEARCH-REPORTWO2014111858
OPPOSITIONEP3093348
OPPOSITIONEP3625345
OPPOSITIONUS2005102713
OPPOSITIONWO0061746
OPPOSITIONWO2012045075
OPPOSITIONWO2013052523
OPPOSITIONWO2014111858
OPPOSITIONWO2014152774
OPPOSITIONWO2016184576
OPPOSITIONWO2017070626
OPPOSITIONWO2017103088
OPPOSITIONWO2018081459
OPPOSITIONWO2018160540
OPPOSITIONWO2018213789
OPPOSITIONWO9837189

Non-Patent Literature (NPL) Citations (42) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "Homo sapiens BCL7B, BAF complex component (BCL7B), transcript variant 1, mRNA", Nucleotide, (20181111), Database accession no. NM_001707.3, URL: NCBI, XP093167504-
OPPOSITION- Anonymous, "Homo sapiens cathepsin D (CTSD), mRNA", Nucleotide, (20181013), Database accession no. NM_001909.4, URL: NCBI, XP093167481-
OPPOSITION- Anonymous, "Homo sapiens complement C3 (C3), mRNA ", Nucleotide, (20190507), Database accession no. NM_000064.3, URL: NCBI, XP093167487-
OPPOSITION- Anonymous, "Homo sapiens complement C8 gamma chain (C8G), mRNA", Nucleotide, (20180429), Database accession no. NM_000606.2, URL: NCBI, XP093167493-
OPPOSITION- Anonymous, "Homo sapiens creatine kinase, brain (CKB), mRNA ", Nucleotide, (20110814), Database accession no. NM_001823.3, URL: NCBI, XP093167479-
OPPOSITION- Anonymous, "Homo sapiens cytochrome P450 family 2 subfamily E member 1 (CYP2E1), mRNA", Nucleotide, (20181021), Database accession no. NM_000773.3, URL: NCBI, XP093167491-
OPPOSITION- Anonymous, "Homo sapiens family with sequence similarity 120A (FAM120A), transcript variant 1, mRNA ", Nucleotide, (20180923), Database accession no. NM_014612.4, URL: NCBI, XP093167509-
OPPOSITION- Anonymous, "Homo sapiens hydroxysteroid 11-beta dehydrogenase 2 (HSD11B2), mRNA", Nucleotide, (20181112), Database accession no. NM_000196.3, URL: NCBI, XP093167512-
OPPOSITION- Anonymous, "Homo sapiens LUC7 like 2, pre-mRNA splicing factor (LUC7L2), transcript variant 1, mRNA", Nucleotide, (20180625), Database accession no. NM_016019.4, URL: NCBI, XP093167516-
OPPOSITION- Anonymous, "Homo sapiens menin 1 (MEN1), transcript variant 1, mRNA", Nucleotide, (20220206), Database accession no. 093167498, URL: NCBI, XP093167539-
OPPOSITION- Anonymous, "Homo sapiens syndecan 3 (SDC3), mRNA", Nucleotide, (20181111), Database accession no. NM_014654.3, URL: NCBI, XP093167544-
OPPOSITION- Iacono, M. ; Mignone, F. ; Pesole, G., "uAUG and uORFs in human and rodent 5'untranslated mRNAs", Gene, Elsevier Amsterdam, NL, NL , (20050411), vol. 349, ISSN 0378-1119, pages 97 - 105, XP027872319-
OPPOSITION- Kim Pruitt, "Chapter 18. The Reference Sequence (RefSeq) Database", The NCBI Handbook, (20021009), XP093167568-
OPPOSITION- Kozak, M., "Regulation of translation via mRNA structure in prokaryotes and eukaryotes", Gene, Elsevier Amsterdam, NL, NL , (20051121), vol. 361, ISSN 0378-1119, pages 13 - 37, XP027872452-
OPPOSITION- Maarten H L De Bruun, "Human complement component C3: cDNA coding sequence and derived primary structure (DNA sequence analysis/proteolytic cleavage site/signal peptide/precursor protein/family of plasma proteins)", Proceedings of the National Academy of Sciences of the United States of America, (19850201), vol. 82, no. 3, pages 708 - 712, XP093167578-
OPPOSITION- Marilyn Kozak, "Mini-Review An Analysis of Vertebrate mRNA Sequences: Intimations of Translational Control", Journal of Cell Biology, (19911115), vol. 115, no. 4, pages 887 - 903, XP093167554-
OPPOSITION- Marilyn Kozak, "Nucleic Acids Research An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs", Nucleic Acids Research, (19870101), vol. 15, no. 20, pages 8125 - 8148, XP055318604-
OPPOSITION- Marilyn Kozak, "Structural Features in Eukaryotic mRNAs That Modulate the Initiation of Translation", JOURNAL OF BIOLOGICAL CHEMISTRY, (19911025), vol. 266, no. 30, pages 19867 - 19870, XP093167555-
OPPOSITION- Marilyn Kozak, "Emerging links between initiation of translation and human diseases", Mammalian Genome, (20020801), vol. 13, no. 8, doi:10.1007/s00335-002-4002-5, ISSN 0938-8990, pages 401 - 410, XP055024763
OPPOSITION- Kozak, M., "At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells", Journal of Molecular Biology, Academic Press, United Kingdom, United Kingdom , (19870820), vol. 196, no. 4, doi:10.1016/0022-2836(87)90418-9, ISSN 0022-2836, pages 947 - 950, XP024010432
OPPOSITION- Kozak, M., "At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells", Journal of Molecular Biology, United Kingdom , (19870820), vol. 196, no. 4, doi:10.1016/0022-2836(87)90418-9, ISSN 0022-2836, pages 947 - 950, XP024010432
OPPOSITION- Benfield, P.A. ; Henderson, L. ; Pearson, M.L., "Expression of a rat brain creatine kinase-@b-galactosidase fusion protein in Escherichia coli and derivation of the complete amino acid sequence of rat brain creatine kinase", Gene, NL , (19850101), vol. 39, no. 2-3, doi:10.1016/0378-1119(85)90321-X, ISSN 0378-1119, pages 263 - 267, XP025688293
OPPOSITION- Mariman, E.C.M. ; Broers, C.A.M. ; Claesen, C.A.A. ; Tesser, G.I. ; Wieringa, B., "Structure and expression of the human creatine kinase B gene", GENOMICS, ACADEMIC PRESS, SAN DIEGO., US, US , (19871001), vol. 1, no. 2, doi:10.1016/0888-7543(87)90004-8, ISSN 0888-7543, pages 126 - 137, XP024864799
OPPOSITION- Kozak, M., "Pushing the limits of the scanning mechanism for initiation of translation", Gene, NL , (20021016), vol. 299, no. 1-2, doi:10.1016/S0378-1119(02)01056-9, ISSN 0378-1119, pages 1 - 34, XP004395302
OPPOSITION- Kozak, M., "Initiation of translation in prokaryotes and eukaryotes", Gene, Elsevier Amsterdam, NL, NL , (19990708), vol. 234, no. 2, doi:10.1016/S0378-1119(99)00210-3, ISSN 0378-1119, pages 187 - 208, XP004173091
OPPOSITION- Kozak, M., "Initiation of translation in prokaryotes and eukaryotes", Gene, NL , (19990708), vol. 234, no. 2, doi:10.1016/S0378-1119(99)00210-3, ISSN 0378-1119, pages 187 - 208, XP004173091
OPPOSITION- Bin Li, Xiao Luo, Yizhou Dong, "Effects of Chemically Modified Messenger RNA on Protein Expression", Bioconjugate Chemistry, American Chemical Society, US, US , (20160316), vol. 27, no. 3, doi:10.1021/acs.bioconjchem.6b00090, ISSN 1043-1802, pages 849 - 853, XP055317909
OPPOSITION- UMENO M, ET AL., "Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping and cDNA-directed expression", Biochemistry, American Chemical Society, (19881201), vol. 27, no. 25, doi:10.1021/bi00425a019, ISSN 0006-2960, pages 9006 - 9013, XP002953996
OPPOSITION- Karikó Katalin, Muramatsu Hiromi, Welsh Frank A, Ludwig János, Kato Hiroki, Akira Shizuo, Weissman Drew, "Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability /NIH Author Manuscript/", Molecular Therapy, US , (20081101), vol. 16, no. 11, doi:10.1038/mt.2008.200, ISSN 1525-0016, pages 1833 - 1840, XP055920956
OPPOSITION- J. P. Ferreira, K. W. Overton, C. L. Wang, "Tuning gene expression with synthetic upstream open reading frames", Proceedings of the National Academy of Sciences, National Academy of Sciences, (20130709), vol. 110, no. 28, doi:10.1073/pnas.1305590110, ISSN 0027-8424, pages 11284 - 11289, XP055539495
OPPOSITION- FAUST P L, KORNFELD S, CHRIGWIN J M, "CLONING AND SEQUENCE ANALYSIS OF CDNA FOR HUMAN CATHEPSIN D", Proceedings of the National Academy of Sciences, National Academy of Sciences, (19850801), vol. 82, doi:10.1073/pnas.82.15.4910, ISSN 0027-8424, pages 4910 - 4914, XP002948607
OPPOSITION- Kirtika H. Asrani, Jeremiah D. Farelli, Mary R. Stahley, Rebecca L. Miller, Christopher J. Cheng, Romesh R. Subramanian & Jeffrey M. Brown, "Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA.", RNA BIOLOGY 2011 JAN-FEB, (20180326), vol. 15, no. 6, doi:10.1080/15476286.2018.1450054, ISSN 1555-8584, pages 756 - 762, XP002793471
OPPOSITION- A. Robbins-Pianka, M. D. Rice, M. P. Weir, "The mRNA landscape at yeast translation initiation sites", Bioinformatics, Oxford university press , Surrey, GB, GB , (20101101), vol. 26, no. 21, doi:10.1093/bioinformatics/btq509, ISSN 1367-4803, pages 2651 - 2655, XP055500441
OPPOSITION- Marilyn Kozak, "Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6", The EMBO journal / European Molecular Biology Organization, IRL Press, Oxford, Oxford , (19970501), vol. 16, no. 9, doi:10.1093/emboj/16.9.2482, ISSN 0261-4189, pages 2482 - 2492, XP055275608
OPPOSITION- Berkner Kathleen L, Sharp Phillip A, "Expression of dihydrofolate reductase, and of the adjacent EIb region, in an Ad5-dihydrofolate reductase recombinant virus", Nucleic Acids Research, (19840224), vol. 12, no. 4, doi:10.1093/nar/12.4.1925, pages 1925 - 1941, XP093166806
OPPOSITION- Douglas R. Cavener , Stuart C Ray, "Eukaryotic start and stop translation sites", Nucleic Acids Research, GB , (19910101), vol. 19, no. 12, doi:10.1093/nar/19.12.3185, ISSN 0305-1048, pages 3185 - 3192, XP093166798
OPPOSITION- So Nakagawa, Yoshihito Niimura, Takashi Gojobori, Hiroshi Tanaka, Kin-ichiro Miura, "Diversity of preferred nucleotide sequences around the translation initiation codon in eukaryote genomes", Nucleic Acids Research, (20080201), vol. 36, no. 3, doi:10.1093/nar/gkm1102, pages 861 - 871, XP002493082
OPPOSITION- D. H. Mathews, "Folding and Finding RNA Secondary Structure", Cold Spring Harbor Perspectives in Biology, Cold Spring Harbor Laboratory Press, United States, United States , (20101201), vol. 2, no. 12, doi:10.1101/cshperspect.a003665, ISSN 1943-0264, pages a003665 - a003665, XP093167584
OPPOSITION- A. G. Hinnebusch, I. P. Ivanov, N. Sonenberg, "Translational control by 5'-untranslated regions of eukaryotic mRNAs", Science, US , (20160617), vol. 352, no. 6292, doi:10.1126/science.aad9868, ISSN 0036-8075, pages 1413 - 1416, XP055478070
OPPOSITION- Kristy Damjanovich;Carmen Langa;Francisco J Blanco;Jamie McDonald;Luisa M Botella;Carmelo Bernabeu;Whitney Wooderchak-Donahue;David A Stevenson;Pinar Bayrak-Toydemir, "5'UTR mutations of ENG cause hereditary hemorrhagic telangiectasia", Orphanet Journal of Rare Diseases, Lo , (20111222), vol. 6, no. 1, doi:10.1186/1750-1172-6-85, ISSN 1750-1172, pages 1 - 11, XP021131723
OPPOSITION- J. R. Babendure, Babendure Jennie L, Ing Jian-Huad, Tsien Roger Y, "Control of mammalian translation by mRNA structure near caps", RNA, COLD SPRING HARBOR LABORATORY PRESS, US, US , (20060101), vol. 12, no. 5, doi:10.1261/rna.2309906, ISSN 1355-8382, pages 851 - 861, XP055470459
OPPOSITION- Grzegorski Steven J., Chiari Estelle F., Robbins Amy, Kish Phillip E., Kahana Alon, "Natural Variability of Kozak Sequences Correlates with Function in a Zebrafish Model", PlosOne, US , (20140923), vol. 9, no. 9, doi:10.1371/journal.pone.0108475, ISSN 1932-6203, pages 1 - 6, XP093166813

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents